Skip to main
AHCO
AHCO logo

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 30%
Hold 20%
Sell 10%
Strong Sell 0%

Bulls say

AdaptHealth Corp demonstrated robust performance in its Sleep segment, achieving a 3.4% year-over-year revenue growth and maintaining a consistent new start rate of over 120,000 for three consecutive quarters. The company has also shown strong financial flexibility by reducing its term loan balance by approximately $50 million, leading to an improved net leverage ratio of 2.79x, moving closer to its 2.5x target while also reporting a stellar free cash flow of $235.8 million, up 64.7% year-over-year. With plans to invest in technology enhancements, expanded capabilities, and strategic acquisitions, AdaptHealth is well-positioned for continued growth and increased market share in the healthcare-at-home solutions industry.

Bears say

AdaptHealth Corp is anticipated to experience a year-over-year revenue decline of 3% to 4% in the first quarter, largely due to weaknesses in its Diabetes segment and a challenging purchase/rental mix impacting overall performance. The company has revised its revenue estimate down from $3.309 billion to $3.230 billion, reflecting a modest decline of 0.9% and projecting adjusted EBITDA of $672 million, a decrease from $691 million, indicating difficulties in achieving organic growth and operational leverage. Additionally, management's expectation that not all payment term benefits from 2024 will recur in 2025 further contributes to a cautious outlook, compounded by the forecasted downside scenario suggesting significant integration challenges and lower-than-expected EBITDA margins.

AdaptHealth Corp (AHCO) has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 30% recommend Buy, 20% suggest Holding, 10% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Buy based on their latest research and market trends.

According to 10 analysts, AdaptHealth Corp (AHCO) has a Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.